🔓
Sign in as a Member to unlock the full view of ROIV. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
ROIV

Roivant Sciences Ltd.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $19.43B

Roivant Sciences Ltd. is a healthcare company focused on developing and commercializing medicines, with a single executive branch holding by Howard Lutnick valued between $1M-$5M and one congressional trader executing 8 transactions in 2025.

Next filing → your inbox
Govt Dependence
10/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat ROIV does

Roivant Sciences Ltd. operates as a healthcare company that identifies, develops, and commercializes innovative medicines across various therapeutic areas. Its business model involves creating subsidiary companies (Vants) to advance drug candidates, leveraging partnerships and strategic investments. Revenue is generated through drug development collaborations, licensing agreements, and potential future product sales.

12 months past · 3 months futureROIV activity timeline

$43$31$19 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $41.85 hi $20.10 lo $39.53 CONGRESS 8 INSIDERS 0 13F FUNDS 30 BILLS 30 AQR Capital Management · + $234M · 2026-06-30Viking Global Investors · - $222M · 2026-06-30Citadel Advisors · + $206M · 2026-06-30Viking Global Investors · holds $184M · 2026-03-31AQR Capital Management · OPENED $162M · 2026-03-31Point72 Asset Management · + $159M · 2026-06-30Viking Global Investors · - $140M · 2025-12-31D.E. Shaw & Co. · + $105M · 2026-06-30Citadel Advisors · + $75M · 2026-03-31Citadel Advisors · + $50M · 2025-12-31D.E. Shaw & Co. · + $39M · 2026-03-31Point72 Asset Management · OPENED $27M · 2026-03-31D.E. Shaw & Co. · - $6M · 2025-12-31 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 0 congressional trades shown · 0 insider buys · 13 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsROIV held by Trump-administration officials

1 cabinet/senior official reported ROIV positions in OGE Form 278 disclosures across 1 filings.

Lifetime Government AwardsROIV federal contracts

ROIV doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding ROIV

$926.8M
Total ROIV held by tracked 13F funds
6
Funds with ROIV positions
+1
Funds opened this quarter
AQR Capital Management $234M +12% 2026-06-30
Viking Global Investors $222M -6% 2026-06-30
Citadel Advisors $206M +113% 2026-06-30
Point72 Asset Management $159M +361% 2026-06-30
D.E. Shaw & Co. $105M +113% 2026-06-30
Two Sigma Investments $779K opened 2026-06-30

Politicians Trading ROIVMembers of Congress with recent ROIV positions

1 politicians traded ROIV across 8 disclosed transactions totaling $64K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ROIV). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading ROIV

2025-10-30 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000
2025-10-31 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000
2025-10-31 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000
2025-06-17 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000 57d late
2025-06-17 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000 57d late
8+ trades on file · most recent 2025-11-21

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

12
stock awards · $1.3M market value
18
option exercises · $11.4M
2026-10-23 Oren Ilan Director AWARD 810 sh $30K
2026-10-23 Epperly Melissa B, Director AWARD 513 sh $19K
2026-10-23 MOMTAZEE JAMES C Director AWARD 383 sh $14K
2026-09-16 Fitzgerald Meghan Director AWARD 5,054 sh $200K
2026-09-16 Gold Daniel Allen Director AWARD 5,054 sh $200K
2026-09-16 Epperly Melissa B, Director AWARD 5,054 sh $200K
2026-09-16 Oren Ilan Director AWARD 5,054 sh $200K
2026-09-16 MANCHESTER KEITH S Director AWARD 5,054 sh $200K
For ROIV, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting ROIVLive legislation impacting this stock

Political ProfileWhere ROIV sits in Washington

[object Object]

STRUCTURAL: No lobbying spend (get_political_influence.lobbying.total_income: 0), no donations, no federal contracts (get_government_precedent.federal_contracts_summary: null). EVIDENTIARY: Single executive branch holding by Howard Lutnick valued $1M-$5M (get_executive_branch_exposure.by_ticker[0].holdings[0].value_bucket), one congressional trader (M001136) with 8 mixed transactions in 2025. Net: Limited direct political engagement but some high-level exposure.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • General healthcare legislation impacting revenue
    Congress
    "Recent bill_impacts shows 8 healthcare bills with impact_ratios 0.0002-0.0003, estimated revenue impacts $3.19M-$6.06M"

Regulatory opportunities

  • Potential favorable healthcare legislation
    Congress
    "Recent bill_impacts shows multiple healthcare bills, though impact ratios are low (0.0002-0.0003)"

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

  • No specific congressional critics identified.
Member intelligence layer

Live signals + predictions for ROIV — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout ROIV & political exposure

Does Roivant Sciences Ltd. (ROIV) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Roivant Sciences Ltd.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own ROIV stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in ROIV on their OGE 278 financial disclosures, including Howard Lutnick. See the Cabinet Conflicts panel for details.
Has Congress traded ROIV stock?
8 congressional trades by 1 unique members of Congress, most recently on 2025-10-31. See the Congressional Trading panel for politician-by-politician breakdown.
What is ROIV political risk profile?
Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track ROIV political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ROIV data is updated daily from these official federal sources.